Q2 FY26: revenue up 16%, but profit after tax down 39% to Rs 383 lakh

Revenue Growth 20pctResults RestatedEbitda Margin CompressionNegative Operating CashflowResults View source PDF Explain this filing

CHEMBOND · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-2.9%Reaction day

₹167.90

prior close

₹166.70

announcement price

After-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used+1.0%-3.9% vs market

On the reaction day the stock moved 3.9 pts less than Nifty Microcap 250, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

-1.5

10m

-0.1

15m

-0.4

30m

-1.6

Sessions after the filingfrom the prior close

StockMarketvs market

Reaction day

-2.9+1.0-3.9

Next day

+1.3+2.0-0.8

-2.3+1.6-3.8

-1.7+1.2-2.9

-1.7+1.6-3.4

-0.5+1.9-2.4

+7.9+2.1+5.8

15d

+7.5+1.0+6.4

+3.6+0.2+3.5

-4.9-3.1-1.8

-14.8-10.9-3.9

UpDownMarket · Nifty Microcap 250Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Q2 FY26 (Sep 2025) unaudited: consolidated revenue Rs 5,775 lakh, up 16% year on year; half-year revenue Rs 11,543 lakh, up 20%. Q2 profit after tax fell 39% to Rs 383 lakh (EPS Rs 2.85) and half-year profit dropped 29% to Rs 782 lakh on lower margins and other income. Animal Health swung to profit. Half-year operating cash flow was negative Rs 391 lakh; review found no qualification.

Likely market impact

Sales grew but profit fell sharply and cash flow turned negative, a negative near-term signal; low borrowing limits balance-sheet risk.